One thousand arrhythmia patients treated using Stereotaxis robotic system

Hannu Parikka and Pekka Raatikainen at the control station of the first Genesis RMN lab in Helsinki, Finland

Stereotaxis has announced that over 1,000 cardiac arrhythmia patients have been treated using the Genesis Robotic Magnetic Navigation (RMN) system.

Genesis RMN, was first used in late 2020 following regulatory clearances in the USA and Europe. Since then, physicians at eight global hospitals have treated over 1,000 patients using Genesis RMN.

Hospitals include Helsinki University Central Hospital, Helsinki, Finland, Banner University Medical Center Phoenix, Phoenix, USA, Princess Grace Hospital Center, Monaco, Missouri Baptist Medical Center, St Louis, USA, HonorHealth Scottsdale Shea Medical Center, Scottsdale, USA, National Institute of Cardiology, Warsaw, Poland, Corewell Health Meijer Heart Center, Grand Rapids, Michigan, and Broward Health Medical Center, Fort Lauderdale, USA. Additional hospitals are in the process of installing the technology with a total of nearly two dozen robotic systems ordered, the company said in a press release.

“We are pleased to celebrate the pioneering physicians and hospitals that demonstrated the clinical value of Genesis RMN for patients, physicians, and health systems through robust regular use,” says David Fischel, chairman and CEO of Stereotaxis.


Please enter your comment!
Please enter your name here